STUDIES ON CYCLOPHOSPHAMIDE-INDUCED TOLERANCE TO SHEEP ERYTHROCYTES by Aisenberg, Alan C.
STUDIES  ON  CYCLOPHOSPHAMIDE-INDUCED  TOLERANCE 
TO  SHEEP ERYTHROCYTES* 
BY ALAN C. AISENBERG, M.D. 
(From the John Collins Warren Laboratories of the Huntington  Memorial  Hospital  of 
Harvard  University at the Massachusetts General Hospital,  Boston, Massachusetts) 
(Received for pubficafion 28 December 1966) 
Immunological  tolerance  remains  a  fundamental  but  incompletely under- 
stood problem in immunology (1, 2). Of the several varieties of such tolerance, 
that induced by immunosuppressive drugs (3) affords several advantages in the 
study of the general problem. Immunosuppressive drugs produce tolerance to a 
variety of antigens in  adult  animals under conditions that  can be controlled 
and  varied  (4).  Further,  these  drugs  produce  metabolic  alterations  which, 
though  multiple,  are  well-known,  and  can  therefore be  correlated  with  the 
resulting immune suppression. 
The present study concerns immunological tolerance to sheep erythrocytes 
produced in  CBA  mice  with  the immunosuppressive drug cyclophosphamide 
(Cytoxan). This cytotoxic alkylating agent is effective in the mouse, producing 
complete tolerance at dosage well below that which causes any fatal toxicity 
(5, 6). Employing sheep erythrocytes and the Jerne plaque technique (7, 8), it 
is possible to obtain information about the cellular kinetics of developing toler- 
ance  and  recovery there-from which  is  unavailable  from antibody methods. 
With  isotopic methods,  deoxyribonucleic acid  and  ribonucleic acid  synthesis 
can be measured and correlated with the induction of tolerance. Finally, be- 
cause both the clearing of foreign erythrocytes from the blood (9,  10) and the 
cytoxic effect of cyclophosphamide (11)  are prompt, the chronology of events 
can be established with precision. This paper deals with tolerance induction in 
this  system, and a  subsequent one will consider recovery  from tolerance and 
the effect of the thymus. 
Methods 
Animals and Mater*:a2s.--Female  CBA mice 10-14 wk of age obtained from the Jackson 
Laboratory, Bar Harbor, Mdme, were used. Cyclophosphamide  (Cytoxan, Mead Johnson 
Laboratories, Evansville,  Ind.) was injected intraperitoneally  as a freshly made saline solution 
containing 5 mg per ml. The usual tolerance-inducing  drug dose  was 330 mg per kg given either 
as a single dose or as four daily divided doses. Unless otherwise  stated, the tolerance-inducing 
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injection of antigen was 0.8 ml of a  30% suspension  (6.4  X  109 cells) of once saline-washed' 
fresh sheep cells  (obtained weekly from Baltimore Biological Laboratories, Baltimore, Md.) 
administered intravenously at the same time as the cyclophosphamide. All experimental points. 
in the present study represent the arithmetic mean of at least three animals. HemagglutAnation 
and hemolysin taters were determined with fresh sheep cells in the Microtiter apparatus  (12) 
employing standard methods (13) and an initial serum dilution of 1:10. 
Determination of Antibody-Forming Cdls.--Hemolyfin-producing  spleen  cells were  enu- 
merated by the technique of Jerne et al. (7, 8). 4 days after intravenous challenge with 0.25 
ml of 10% sheep cells, animals were sacrificed  and the individual spleens sieved with a Cyto- 
sieve (Will Scientific, Inc., Cambridge, Mass.) into 2.0 mi of Gey's balanced salt solution, The 
spleen cell suspension  was counted in a hemocytometer and diluted or concentrated to give a 
convenient number of plaque-forming cells in a 0.1 ml volume (50-1000 plaque-forming cells). 
One-half ml of 2.5% agarose (SeaKem brand, obtained from Bausch and Lomb Incorporated~ 
Rochester, N.  ¥., and dissolved in Gey's solution by heating for 1 hr at atmospheric pres- 
sure in a  steam  chamber)  solution was added to 1.5 mi of  Gey's solution  heated  to  46°C, 
and to this were added 0.1  ml of the spleen cell suspension and 0.1 ml of 15% washed sheep. 
cells, both at room temperature. After miring, this cell suspension was poured into a  100  X 
15  mm  disposable Petri dish (Falcon)  into which a  sublayer  of 10 ml of 1.2% agarose had 
been poured the previous day. When the agarose cell suspension  had gelled, the dish was in- 
cubated at 37°C for 2 hr. The 19S or direct hemolytic plaques were developed by adding com- 
plement (1 ml of a 1:10 dilution of lyophilized guinea pig serum obtained from Baltimore Bio- 
logical Laboratories) and incubating for an additional hour. Indirect or 7S plaques were deter- 
mined on duplicate plates by the method of Dresser and Wortis (14),  employing  a  rabbit 
antiserum  to mouse gamma globulin  (mouse Fraction H,  Pentex  Incorporated,  Kankakee, 
ill.).  Following the initial 2-hr incubation, plates were incubated for 1 hr with a 1:50 dilution 
of rabbit antiserum prior to the complement addition. The hemolytic plaques surrounding each 
antibody-forming  cell were  enumerated  with  the  aid  of  a  bacteria  colony counter  (New 
Brunswick  Scientific Co., New Brunswick, N. J.). 
Determination of Rates of Deoxyribonudeic Acid  (DNA)  and  Ribonucleic Acid  (RNA) 
Syntkesis.--Tha  techniques employed were modified from those described by Dalgarno and 
Martin (15). Mice to be analyzed for DNA synthesis received 15 #c of thymidine-methyl-SH 
(28 mc per rag, obtained from New England Nuclear Corp., Boston, Mass.) by intraperitoneal 
injection 4 hr before sacrifice,  while mice to be analyzed for RNA synthesis received 15 #c 
of uridine-SH (19 mc per rag) 2 hr before sacrifice. The whole spleen was excised, weighed, and 
homogenized in 8 ml of cold 0.25 ~s sucrose with a Potter-Elvehjem homogenizer. The nuclear 
fraction was separated from the cytoplasm by sedimentation at 600 g for 10 rain in the cold 
and then resuspended in 8 mi of cold sucrose.  2 ml portions of 1 ~s perchloric acid were added' 
to the nuclear and to the cytoplasmic fractions. The precipitated nuclear and cytoplasmic 
fractions were then washed  (by centrifugation)  three times with cold 0.1 u  perchloric acid, 
extracted with cold 2:1 ether:methanol, defatted for 30 rain at room temperature with 1:1 
methanol:chloroform, washed twice with ether, and suspended overnight at 37°C in 1 mi of 
0.3 ~  KOH to hydrolyze the RNA. The following morning the KOH solution was chilled and 
neutralized with 0.63  ml of  20%  trichloracetic acid. The precipitated DNA was separated 
from the RNA in the supernatant by centrifugation, and then washed with 1 ml of cold 5% 
trichloracetic  acid.  The  combined  supernatants  were used for RNA determination by the 
orcinol method  (16)  and  radioactivity measurement  by  scintillation  counting.  The  DNA 
precipitate was next suspended in 1 ml of 5% trichloracetic acid and  hydrolyzed by heating 
for 30 rain at 90°C in a covered tube. Following centrifugation, the DNA was measured with 
diphenylamine (17) and counted. 
DNA was studied in the nuclear fractions of the animals receiving thymidine, and RNA ALAN C.  AISENBERG  835 
was examined in the nuclear and cytoplasmic fractions of animals receiving uridine. ~  ml 
portions of RNA or DNA digests were counted in 10 ml of dioxane scintillation fluid (200 g 
sdntiUation grade naphthalene, 10 g PPO, 0.25 g POPOP, 100 ml toluene per liter of purified 
dinxane) in a Packard "Tricarb" liquid scintillation spectrometer. 
RESULTS 
Temporal Relationship of Drug to Antigen for Tolerance Induction.--Fig.  1 
presents data from an experiment designed to explore the time relationships of 
antigen injection and drug administration in the induction of tolerance. Cyclo- 
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Fxo. 1. Relationship of the times of sheep cell injection and cydophosphamide  administra- 
tlon in drug-induced immunological tolerance. 
phosphamide was injected intraperitoneally as a  single dose of 330 mg per kg 
or 165 mg per kg on the day of sheep cell  administration or on various days 
before or after the  antigen.  The tolerance-inducing sheep  cell injection was 
6.4 X  109 cells (0.8 ml of a 30% suspension), and tolerance was maintained by 
weekly intraperitoneal injections of 0.2 ml of 10%  sheep cells.  The data re- 
corded in the figure are the hemagglutination titers 35 days after the initial 
sheep cell injection. 
It  will be seen from Fig.  1  that  a  precise relationship exists between the 
times of antigen and drug injection to produce complete tolerance. Thus at the 
higher drug dose,  complete tolerance is produced when cyclophosphamide is 
given together with antigen, the day after antigen, and 1 or 2 days before, while 836  CYCLOPHOSPHAMIDE-INDUCED TOLERANCE 
tolerance is almost complete when the drug is given 3 days before antigen or 
delayed until the 2nd day after. The lower drug dose defines more precisely the 
period of maximum tolerance induction to the day of antigen and the day im- 
mediately prior. 
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FIO. 2. Influence of antigen dose on cyclophosphamide-induced immunological tolerance. 
The sheep cell injection was followed immediately by cyclophosphamide. 
Antigen Dose.--Fig. 2 presents data on the effect of antigen dose on tolerance 
induction. In this experiment sheep cells in varying amounts were injected in- 
travenously, followed immediately by a single dose of cyclophosphamide (330 
mg per kg). On the 14th day the animals  received the usual challenge of sheep 
cells and the spleens were plaqued 4 days later. It will be noted that the spleens ALAN C.  ~S~mERO  837 
of animals  that  received cyclophosphamide without sheep  cells  contain only 
one-sixth the number of plaque-forming cells of those from animals that re- 
ceived no drug (32,000 plaques compared to 178,000).  Furthermore, it is only 
at the highest sheep cell dose (6.4 X  l0  g cells) that essentially complete specific 
immunological tolerance is achieved--reduction of the plaque count to 12 per 
TABLE I 
DNA and RNA Metabolism in Mouse Spleen at Various Times after 
Cyclophosplmmide Administration 
Experi-  Cytoxan 
ment  Day  dose* 
No. 
DNA  Nuclear RNA  Cytoplasmic  RNA 
Specific  Specific  Specific 
/~g  cpm  activity  ~g  cpm  activity  #g  cpm  activity 
0  --  1080  9100  8.4  147  996  6.8  197  1070  5.4 
1  330  260  108  0.4  43  210  4.9  101  292  2.9 
2  330  294  175  0.6  37  178  4.8  84  399  4.8 
3  330  254  llS  0.5  35  156  4.4  144  430  3.0 
4  330  235  330  1.4  32  180  5.7  140  722  5.1 
5  330  200  340  1.7  52  240  4.6  137  --  -- 
6  330  394  3070  7.9  113  440  4.0  182  970  7.1 
2  0  --  980  5314  5.4  125  391  3.1  149  474  3.2 
1  165  517  227  0.4  95  213  2.2  137  172  1.3 
1  82  739  2091  2.8  109  343  3.1  149  302  2.0 
2  165  436  556  1.3  65  135  2.0  116  225  1.9 
2  82  647  1202  1.9  78  236  3.0  130  223  1.7 
3  165  442  872  1.9  56  229  4.1  108  196  1.8 
3  82  648  2098  3.2  82  280  3.4  134  379  2.8 
4  165  418  1193  4.8  65  301  4.6  123  219  1.7 
4  82  638  1837  2.9  88  286  3.3  129  188  1.4 
* In mg per kg injected on day 0. 
spleen.  This highest dose is 0.8 ml of a  30%  spleen cell  suspension and ap- 
proaches the maximum intravenous dose that is tolerated by mice as a  single 
injection. Experiments not included in this figure indicate that cyclophospha- 
mide tolerance to sheep cells does not follow injection of ox or rabbit erythro- 
cytes. 
Response of Spleen DNA and RNA Synthesis to Cyclophosphamide.--Tables 
I and II present data from two experiments in which DNA and RNA synthesis 
following  cyclophosphamide  administration  were  studied.  In  Table  I  the 
actual data of quantity, rate of synthesis, and specific activity of DNA, nuclear 838  CYCLOPHOSPHAMIDE-INDUCED  TOLERANCE 
RNA,  and cytoplasmic RNA  are presented. Table II compares  the synthetic 
rates to those of animals who have not received cyclophosphamide, and includes 
antibody titers from a  parallel group of animals challenged with sheep cells on 
the day the rate of synthesis was determined. The point to be made is that in 
TABLE II 
Rdative Rates of DNA and RNA Synthesis  and Immunosuppression at Various  Times 
after Cydophosphamide 
Experiment 
No.  Day 
2 
3 
Cytoxan 
dose* 
330 
330 
330 
330 
330 
330 
165 
82 
165 
82 
165 
82 
165 
82 
DNA 
synthesis:~ 
1.00 
0.05 
0.07 
0.06 
0.17 
0.20 
0.94 
1.00 
0.07 
0.52 
0.24 
Nuclear 
RNA 
synthesis~ 
1.00 
0.72 
0.69 
0.65 
0.84 
0.68 
0.59 
1.00 
0.71 
1.00 
0.65 
Cyt~L~mic 
synthesis~ 
1.00 
0.54 
0.89 
0.56 
0.94 
1.32 
1.00 
0.41 
0.65 
0.59 
0.35 
0.35 
0.59 
0.89 
0.54 
0.97  0.53 
1.32  0.56 
1.10  0.91 
1.48  0.53 
1.06  0.44 
Antibody 
fiters~ 
10 
0 
0 
0.7 
8.7 
9 
11.3 
0 
12 
10 
12 
11 
12 
11 
11 
* In mg per kg on day 0. 
:~ Derived from Table I  and expressed as ratio of specific activity to specific activity on 
day 0. 
§ Average hemagglutination titer expressed  as log2/10.  Cyclophosphamlde was given to 
separate groups of 3 animals and sheep cells injected on the day indicated. The animals were 
bled and titered 30 days later. The figures for nucleic acid synthesis were those existing at 
the time sheep cells were injected in these animals. 
both Experiments I  and II, best appreciated in Table II, profound suppression 
of immunological responsiveness correlated with profound depression of DNA 
synthesis at the time antigen is injected. Thus,  complete immunological toler- 
ance  was  associated with  DNA-specific  activities which  were  less  than  one- 
tenth those of the untreated spleen. No similar correlation of immune suppres- 
sion with nuclear or cytoplasmic RNA synthesis is evident. ~AN C.  AISENBEaG  839 
It will also be noted in Experiment I  (Table I) that the amounts of DNA and 
nuclear RNA fall to about 20 % of their precyclophosphamide levels, the maxi- 
mum depression occurring on the 4th or 5th day after drug injection. However, 
the reduction  of cytoplasmic RNA is much less,  the minimum level of cyto- 
plasmic RNA is still more than 40 % of the predrug level. 
TABLE III 
Pla~ue-Forming Spleen Cells 4, 6, and 17 Days after Cydophospkamide Administration 
which was Begun Various Times after the Injection of Sheep Erythrocytes 
! Plaques 4 days  Plaques 6 days  Plaques  17 days 
Day cytoxan begun*  Plaques on day  after cytoxan  after cytoxan  after  cytoxan 
cytoxan begun~  begun  begun  begun 
Day 0 
19S plaques 
7S plaques 
Day 2 
19S plaques 
7S plaques 
Day 3 
19S plaques 
7S plaques 
Day 4 
19S plaques 
7S plaques 
Day 14 
19S plaques 
7S plaques 
Day 28 
19S plaques 
7S plaques 
Day 46 
19S plaques 
7S plaques 
120 
8 
2800 
56 
20,800 
10,800 
50,000 
42,000 
750 
5300 
305 
1470 
235 
550 
1 
0 
3 
0 
50 
18 
52 
22 
83 
117 
1 
0 
4 
0 
40 
16 
39 
24 
56 
35 
36 
16 
3 
0 
3 
2 
1900 
1260 
520 
510 
238 
119 
102 
151 
* 0.8 ml of 30% sheep cells injected day 0. 82 mg per kg of cyclophosphamide  daily for 4 
days. All results are expressed in plaques per spleen. 
:~ These animals received no cyclophosphamide. 
Analysis of Spleen Plaques when Cyclophosphamide is Begun at Varying Times 
after  Sheep Cell Administration.--It  was noted in Fig.  1 that a  single dose of 
cyclophosphamide (330 mg per kg), given with sheep cells or 1 or 2 days after 
sheep  cell  injection,  was  associated  with  essentially complete immunological 
tolerance, while if the drug was delayed until the 3rd day there was virtually no 
induction  of tolerance.  In order to investigate those  events  taking place  be- 
tween days 2 and 3 which change drug sensitivity so remarkably, the alterations 
in antibody-forming cells of the spleen have been analyzed when cyclophospha- 840  CYCLOPHOSPHAMIDE-INDUCED  TOLERANCE 
mide is given after sheep cells on various days (Table III). Thus cyclophospha- 
mide was given as a 4 day course (82 mg per kg per day) beginning the day of 
sheep cell injection, or beginning 2, 3, 4,  14, or 28 days thereafter. In each in- 
stance the 19S and 7S hemolysin-producing plaques of the spleen were deter- 
mined on the day cyclophosphamide was begun and 4, 6,  and 17  days later, 
each time point representing the spleens from three animals. 
In Table III, the first two columns of data, scanned vertically, indicate the 
sequence of 19S and 7S antibody-forming cells following sheep cell challenge in 
the  absence  of immunosuppressive drug.  The  results  of this  experiment are 
representative of those we have seen.  Thus, in our studies 19S cells appear in 
large numbers only on the 2nd day after sheep cell injection, reach a maximum 
on the 4th day, and decline rather rapidly over the ensuing week. Cells produc- 
ing 7S antibody appear in significant numbers a day later (day 3) and decline 
much more slowly. It will be observed that between days 2 and 3, the period 
during which sensitivity to cyclophosphamide is lost, there are marked altera- 
tions in the number of both 19S and 7S plaque-forming cells: 19S cells increase 
8-fold and 7S cells increase 200-fold. 
For the sake of simplicity, data on the total number of spleen cells has not 
been included in the table. On the day cyclophosphamide was begtm, the com- 
bined average spleen cell number was 156 million, on day 4 after cyclophospha- 
mide the average was 36 million, on day 6 it was 32 million, and on day 17 it 
was 156 million. The period of observation included in the table encompasses 
the period of restoration of the total number of spleen cells. 
The remaining columns of Table III list the 19S and 7S plaque-forming cells 
4, 6, and 17 days after the initial drug injection. Thus, when cyclophosphamide 
is begun the day of sheep cells or 2 days later, there is complete disappearance 
of hemolysin-producing plaques by drug day 4 and continued absence on day 
17. This continued absence of plaques confirms the antibody data that cyclo- 
phosphamide  administered on  these  days produced  complete  immunological 
tolerance. 
Cyclophosphamide administered 3 days or more after antigen injection, on 
the contrary, leaves a considerable number of both 19S and 7S plaque-forming 
cells 17 days after treatment, when the spleen is restored to its pretreatment cell 
number. When the drug is begun 3, 4, or 14 days after antigen there is a con- 
siderably greater depression of plaque-forming cells on days 4 and 6 post-drug, 
at the height of cyclophosphamide effect, than on postdrug day 17 when the 
spleen cell level has returned to normal. Indeed, it has been found that the 
same amount of cyclophosphamide (330 mg per kg) injected as a  single  dose 
(rather than 4 daily divided doses) results in no detectable plaque-forming cells 
4 days after the drug has been administered, in those animals which had re- 
ceived antigen 3 and 4 days earlier. However, substantial numbers of plaque- 
forming cells  are  again present  on the  17th  postdrug day in  these  animals, 
indicating that complete tolerance was not induced. ALAN c.  AISE~mERG  841 
DISCUSSION 
The experiments reported here confirm the work of others (5, 6) on the effec- 
tiveness of cyclophosphamide as an immunosuppressive  agent.  The ability to 
completely suppress antibody against sheep cells (18), a strong antigenic stimu- 
lus, indicates a high order of effectiveness in the mouse. The finding that maxi- 
mum immunosuppression is achieved when cyclophosphamide is injected in the 
24 hr before antigen is also consistent with the work of other investigators em- 
ploying irradiation  (19) and some immunosuppressive drugs (20, 21), although 
with other drugs  and antigens  maximum  depression has been obtained when 
the antigen is injected first (20, 21). 
It was at first puzzling that a much higher dose of antigen was necessary for 
complete drug-induced  immunological  tolerance  (6.4  X  109 sheep cells)  than 
for the maximum antibody response (2 X  108 cell,  references 8 and  13), since 
it is likely that  the same receptor site is involved in both antibody formation 
and tolerance. The answer to this problem is immediately apparent from a study 
of the relationship of drug-induced tolerance to antigen dose (Fig. 2), where it is 
seen that with an injection of 2 X  10  s sheep cells tolerance is about 90 % com- 
plete. If the same receptor sites were involved in antibody formation,  this re- 
sponse would be 90 %  of maximum,  and available methods for measuring im- 
mune capacity (including the plaque technique) could not be expected to detect 
the difference between 90 and 100 %. It is probable that the increment of sheep 
cells from 2 X  108 to 6.4 X  109 is necessary to reach some 10 % of the receptor 
sites which are relatively sequestered from the antigen source. 
Quantitative  data  derived  from  study  of  antibody-forming  cells  with  the 
Jerue technique indicate that there are two components to cyclophosphamide- 
induced  immunological  suppression.  The  first  is  not  specific  immunological 
tolerance since it is independent  of administered  antigen;  it is nonspecific im- 
mune suppression, presumably persisting lymphoid injury caused by the cyto- 
toxic drug. This nonspecific immune injury accounts for a large fraction (two- 
thirds to five-sixths) of the total immunological suppression seen 18 days after 
the usual dose of cyclophosphamide which was employed in the present experi- 
ments. From an examination of the decrease of DNA (Table I, Experiment  1) 
and  from the fall in  spleen cell count after  cyclophosphamide  injection,  it is 
evident that the fraction of cells destroyed by cyclophosphamide is quantita- 
tively similar to the fraction of nonspecific immune suppression resulting from 
this dose of the drug. Thus the data suggest that this nonspecific immune sup- 
pression may be related to drug-induced cell death. The total number of lym- 
phoid cells of the spleen are restored 18 days after the drug,  but at this time 
they are defective in their immunological  competence.  (A further publication 
will describe the  recovery of competence over ensuing months  under  thymic 
influence.) In reviewing the nucleic acid data (Table I) it is also of interest that 
there  is a  much greater  loss of DNA  and  nuclear  RNA than  of cytoplasmic 842  CYCLOPHOSPHAMIDE-INDUCED  TOLERANCE 
RNA after cyclophosphamide,  suggesting  that the cells killed by the drug are 
poor in cytoplasm. The small lymphocyte is such a cell, poor in cytoplasm. 
The second and remaining  fraction of immunological  suppression  is specific 
immune tolerance; i.e., directed specifically  towards sheep cells and requiring 
sheep cell administration at the time of drug injection.  This immune tolerance 
induction of cyclophosphamide correlates  well in the present experiments with 
profound suppression  of DNA synthesis in the remaining  lymphoid cells of the 
spleen  (those  not  destroyed  by cyclophosphamide).  Thus,  the  nucleic  acid 
evidence favors a  mechanism for cyclophosphamide tolerance in which  toler- 
ance results from immunological  stimulation  in the presence  of profound in- 
hibition of DNA synthesis and mitosis  (21-24).  Further,  it appears plausible 
that the immunological  stimulation of such DNA-damaged cells leads to their 
death, with consequent elimination  of the specific clone (25, 26). Since the pri- 
mary site of action of cyclophosphamide is known to involve DNA (27),  this 
explanation  is  quite acceptable in  connection with  this  compound.  It seems 
reasonable that other immunosuppressive compounds act in the same manner. 
The present experiments do not support the alternate  explanation  that has 
been put  forth  for drug-induced  tolerance,  i.e.  that  these  compounds act  in 
conjunction  with  antigen  to  turn  off the  transcription  of immunological  in- 
formation  within  the receptor or effector  immune  cell via a  ribonucleic  acid 
mechanism  (4, 21). However, it must be pointed out that  the present studies 
measure only average nuclear and cytoplasmic ribonucleic  acid synthesis within 
the spleen; a decrease in synthesis of RNA within a particular cell line or within 
a particular chemical  compartment could go undetected. 
An earlier paper (28) describes the prompt and antigen-specific disappearance 
of  hemolysin-forming  plaques  of  unstimulated  spleen  produced  when  sheep 
erythrocytes and cyclophosphamide are administered at the same time (Table 
III).  This disappearance supports a  clonal  selection  theory of antibody syn- 
thesis  (26, 27), and suggests that the 19S-producing  cell of the resting spleen is 
related to the specific clone which responds to the antigen. 
Less  revealing  has  been  the  attempt  to  analyze  the  events  in  tolerance 
induction when the drug has been given after antigen.  Unfortunately, there is a 
marked  increase  in  both  19S  (8-fold)  and  7S  (200-fold)  cells  between  the 
2nd postantigen day when complete tolerance with cyelophosphamide can still 
be realized,  and the 3rd postantigen day when the drug is no longer effective. 
The information  from our experiments  suggests  that  the  19S cell of the 2nd 
postantigen day is much more sensitive  to cyclophosphamide than  either the 
19S or the 7S cell of the 3rd day. With the passage of time after antigen (day 
14  and  day  28  postantigen),  increasingly  cyclophosphamide-resistant  cells 
emerge,  though the 19S cell appears to be more resistant  than  the 7S ceil at 
these later times.  Thus, particularly with respect to the 19S antibody-produc- 
ing  cell,  our  evidence  suggests  a  progressive  increase  in  resistance  to cyclo- ALAN  C.  AISENBERG  843 
phosphamide during the first 2 wk following antigen. This could be due either 
to a  decrease in the mitotic rate  and consequent loss of sensitivity to cyclo- 
phosphamide  or  to  a  differentiation  to  cells  of less  sensitivity.  The  present 
experiments are consistent with the work of Sahier and Schwartz who, using 6- 
mercaptopurine, found that the 7S response could be eliminated at a dosage which 
left the 19S response intact (29). 
Two factors make analysis of postantigen drug treatment  with the plaque 
technique difficult.  The first is the observation that  during  the peak of drug 
effect there is an eclipse of detectable plaque-forming  cells, with reappearance 
after the drug effect has dissipated.  It follows that  potential plaque-formlng 
cells are present at the peak of cyclophosphamide action but are undetected by 
plaquing  at  that  time.  Such  cells may not  be functioning  because  of drug 
damage, but regardless of the cause, the inability to follow the cells through the 
entire period of drug action makes interpretation of the results ambiguous. The 
second point which makes the analysis difficult is the present uncertainty of the 
relationship of the 19S and 7S cells to each other. 
SU~rM~RY 
Complete immunological  tolerance to sheep cells can be induced in mice when 
cyclophosphamide is injected together with sheep cells or up to 72 hr before or 
48 hr after the antigen.  As is true for radiation-induced  immune suppression, 
the drug is most effective when given in the 24 hr prior to antigen.  Complete 
cyclophosphamide-induced immunological  suppression requires large  doses of 
sheep cells (6.2 X  109 cells), presumably to enable antigen to reach sequestered 
receptor sites. 
The cyclophosphamide tolerance system has been analyzed with the Jerne 
technique  to  determine  plaque-forming  cells  and  with  isotopic  methods  to 
measure rates of nucleic acid synthesis. This drug suppression  has been found 
to consist of two components. The first is nonspecific injury to the lymphoid 
system caused by the cytotoxic drug and is related to the proportion of spleen 
cells killed. The second is antigen-specific  immunological  tolerance and appears 
to correlate with profound depression  of deoxyribonucleic  acid synthesis in the 
surviving cells. This tolerance is thought to be most consistent with a mech- 
anism  in  which  antigenic  stimulation  in  the  presence  of cyclophosphamide- 
inhibited DNA synthesis and mitosis leads to the elimination  or death of the 
specific immunological  clone. 
Tolerance induction with cyclophosphamide is associated with loss of the 19S 
hemolysin plaques which are seen in nonstimulated mouse spleen, implicating 
these cells in immune responsiveness.  The ability to induce tolerance is lost on 
the 3rd postantigen day at the end of a  24-hr period in which 19S cells have 
increased 8-fold and 7S cells 200-fold. The data suggest that loss of sensitivity 
is due to the emergence on day 3 of drug-resistant plaque-forming cells, particu- 844  CYCLOPHOSPHAMIDE-INDUCED  TOLERANCE 
larly those of the  19S variety.  In the  succeeding days after antigen injection 
there is a progressive increase in the resistance of plaque-forming cells to cyclo- 
phosphamide administration. 
I wish to acknowledge the excellent technical assistance of Caroline Davis. 
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